Search
for
Sort by
Research 841–870 of 1000+
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- Abstracts
- Dermatological Issues in a Child with Diabetes Mellitus
- Allergens and Irritants
- Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners.
- Dermatological drugs, topical agents, and cosmetics
- Classified Advertising
- Classified Advertising
- Classified Advertising
- Cytostatics and immunosuppressive drugs
- How to Find Your New Tax Bracket
- PHILADELPHIA DERMATOLOGICAL SOCIETY
- Surgical interventions for androgenetic alopecia
- Complications in Esthetic Surgery
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Large Scale Gene Expression Profiles of Regenerating Inner Ear Sensory Epithelia
- Localisation of members of the notch system and the differentiation of vibrissa hair follicles: Receptors, ligands, and fringe modulators
- How to distinguish medicalization from over-medicalization?
- Stress and Psychoneuroimmunologic Factors in Dermatology
- Understanding and Management of Female Pattern Alopecia
- The zombie commodity: hair and the politics of its globalization
- Trichotillomania in children and adolescents: Review of the literature and case report
- Stem Cell-Based Hair Cell Regeneration and Therapy in the Inner Ear
- Guidelines for the Use of Acitretin in Psoriasis
- The Black identity, hair product use, and breast cancer scale
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Cyberbabes: (Self-) representation of women and the virtual male gaze
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment